Comment by
windymayor1 on Apr 26, 2024 11:09am
Looks like they left $2 in the dust. Next stop margin eligible $3.00!
Comment by
ENEMENEMYNEMO on Apr 28, 2024 8:41am
Someone is angry they missed out!! MDNA is successful , meanwhile you are pumping a nothing burger that's been looking for success from the same product for 25 years with no success. Where they have been successful is suckering in investors with false hope draining many of their savings for what 20 clinical trials that went no where!!!
Comment by
Peladawn on Apr 29, 2024 7:25pm
Oh really?....please explain how it is that they're successful....lol...is that why they just had to borrow $20 mil?....
Comment by
windymayor1 on Apr 30, 2024 1:42pm
Doesn't sound like you understand the biotech sector or equity financing for that matter.
Comment by
Galaxym31 on May 02, 2024 12:00pm
I dont but I did buy 20 000 shares below .45
Comment by
Tarbaby on Apr 29, 2024 11:32am
Agreed..they wouldnt plunk $20M into just any company. They see the potential of MDNA and must be happy with its results so far. This should be a takeover candidate soon. At $1B ++